News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
71,207 Results
Type
Article (1942)
Company Profile (3)
Press Release (69262)
Section
Business (21542)
Career Advice (9)
Deals (4566)
Drug Delivery (1)
Drug Development (8174)
FDA (1810)
Job Trends (803)
News (37141)
Policy (3586)
Tag
Academia (93)
Allergies (8)
Alliances (8188)
ALS (9)
Alzheimer's disease (138)
Antibody-drug conjugate (ADC) (22)
Approvals (1861)
Artificial intelligence (16)
Automation (1)
Bankruptcy (8)
Best Places to Work (586)
Biosimilars (39)
Biotechnology (5)
Bladder cancer (20)
Brain cancer (3)
Breast cancer (30)
Cancer (331)
Cardiovascular disease (8)
Career advice (9)
CAR-T (9)
Cell therapy (36)
Cervical cancer (1)
Clinical research (7204)
Collaboration (152)
Compensation (16)
Complete response letters (3)
COVID-19 (195)
C-suite (36)
Cystic fibrosis (4)
Data (353)
Depression (5)
Diabetes (21)
Diagnostics (606)
Digital health (1)
Drug discovery (19)
Duchenne muscular dystrophy (20)
Earnings (7848)
Events (7169)
Executive appointments (55)
FDA (2065)
Fibrodysplasia Ossificans Progressiva (1)
Funding (89)
Gene editing (3)
Gene therapy (24)
GLP-1 (59)
Government (238)
Grass and pollen (1)
Guidances (33)
Healthcare (1080)
HIV (1)
Huntington's disease (1)
IgA nephropathy (11)
Immunology and inflammation (4)
Indications (7)
Infectious disease (204)
Inflammatory bowel disease (19)
Influenza (7)
Intellectual property (22)
IPO (1646)
Job creations (243)
Job search strategy (9)
Layoffs (6)
Legal (956)
Liver cancer (17)
Lung cancer (63)
Lymphoma (24)
Manufacturing (50)
MASH (9)
Medical device (1138)
Medtech (1140)
Mergers & acquisitions (3050)
Metabolic disorders (53)
Multiple sclerosis (11)
NASH (1)
Neurodegenerative disease (9)
Neuroscience (209)
NextGen: Class of 2025 (221)
Non-profit (62)
Obesity (21)
Opinion (2)
Ovarian cancer (16)
Pain (5)
Pancreatic cancer (10)
Parkinson's disease (23)
Partnered (2)
Patents (35)
Patient recruitment (23)
People (5044)
Pharmaceutical (3)
Pharmacy benefit managers (1)
Phase I (1952)
Phase II (3033)
Phase III (2723)
Pipeline (254)
Policy (1)
Postmarket research (242)
Preclinical (680)
Press Release (2)
Prostate cancer (11)
Radiopharmaceuticals (22)
Rare diseases (35)
Real estate (602)
Regulatory (2710)
Reports (6)
Research institute (94)
RNA editing (1)
RSV (2)
Schizophrenia (10)
Series A (18)
Series B (14)
Service/supplier (1)
Sickle cell disease (3)
Spinal muscular atrophy (4)
Sponsored (1)
Startups (423)
Stomach cancer (1)
Supply chain (9)
Vaccines (33)
Venture capital (2)
Weight loss (5)
Women's health (2)
Date
Today (8)
Last 7 days (42)
Last 30 days (205)
Last 365 days (2703)
2025 (1883)
2024 (3259)
2023 (3822)
2022 (7042)
2021 (6414)
2020 (5934)
2019 (3888)
2018 (3014)
2017 (3569)
2016 (3185)
2015 (4046)
2014 (3025)
2013 (2604)
2012 (2784)
2011 (2904)
2010 (2663)
Location
Africa (87)
Alabama (3)
Arizona (9)
Asia (21708)
Australia (2443)
California (493)
Canada (300)
China (259)
Colorado (4)
Connecticut (19)
Delaware (4)
Europe (12742)
Florida (43)
Georgia (11)
Illinois (22)
India (21)
Indiana (8)
Japan (137)
Kansas (5)
Louisiana (1)
Maine (4)
Maryland (94)
Massachusetts (347)
Michigan (4)
Minnesota (31)
Missouri (3)
Nebraska (1)
Nevada (3)
New Jersey (282)
New York (187)
North Carolina (72)
Northern California (191)
Ohio (3)
Oregon (1)
Pennsylvania (83)
South America (107)
Southern California (234)
Tennessee (1)
Texas (44)
United States (1829)
Utah (14)
Virginia (36)
Washington D.C. (3)
Washington State (26)
Wisconsin (6)
71,207 Results for "cipla ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Exelixis Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Cipla Limited and Cipla USA
Exelixis, Inc. (Nasdaq: EXEL) today announced that it has entered into a Settlement and License Agreement (Agreement) with Cipla Ltd. and Cipla USA, Inc. (collectively Cipla).
May 20, 2024
·
3 min read
Press Releases
Cipla and Formosa sign multi-regional licensing deal for Clobetasol Suspension
March 18, 2025
·
4 min read
Press Releases
Medicus Pharma Ltd. Completes Acquisition of Antev Limited
Antev is developing Teverelix, a next generation GnRH Antagonist, as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate Cancer collecting representing ~US$6 billion in potential market opportunityPatrick J. Mahaffy, a veteran pharma executive and the former Chairman of Antev, appointed to Medicus Board of Directors
September 2, 2025
·
10 min read
Press Releases
Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd.
August 28, 2025
·
5 min read
Press Releases
Tenpoint Therapeutics, Ltd. to Participate in Investor Conferences in September 2025
August 25, 2025
·
1 min read
Press Releases
Faron Pharmaceuticals Ltd: Notice of Half-Year Financial Results
August 19, 2025
·
2 min read
Press Releases
Regenerex Pharma, Inc. Enters Into Binding Supply and Development Agreement with Holista Colltech Ltd.
September 4, 2025
·
3 min read
Press Releases
Medicus Pharma Ltd Announces a Definitive Agreement to Acquire Antev Ltd. UK
Antev Shareholders to Receive Aggregate ~17% Equity Stake in Medicus plus US$65 Million in Contingent Payments
June 30, 2025
·
10 min read
Press Releases
Lifeward Ltd. Reports Second Quarter 2025 Financial Results
August 15, 2025
·
18 min read
Press Releases
Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd
September 4, 2025
·
13 min read
1 of 7,121
Next
